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Pulmonary seed embolization is a complication of prostatic brachytherapy with varying
incidence rates. Key factors that reportedly influence the incidence of seed embolization
include planning volume, quantity of seeds, seed placement, and type of seeds (stranded vs
free). The clinical implications of seed migration are unclear because sequelae were not
demonstrated in multiple short-term studies yet there have been several reports of
long-term complications. We report a case of a 56-year-old patient who presented with
dyspnea approximately 6 years after brachytherapy treatment for a very low-risk prostate
cancer. Chest radiograph showed multiple linear densities overlying the right suprahilar
lung. Computed tomography confirmed the location of the densities within the pulmonary
arteries in the right upper lobe.
© 2016 the Authors. Published by Elsevier Inc. under copyright license from the University
of Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Case report
A 56-year-old African American male former smoker was
referred to urology for a rising prostate-specific antigen and a
history of decreased force of streamandhesitancy. Transrectal
ultrasound with sextant biopsies revealed a moderately
differentiated adenocarcinomawith a Gleason score of 6 (3þ 3)
without evidence of local invasion. Clinically staged as T1c N0
M0, the carcinomawas considered very low risk and low dose-
rate (LDR) brachytherapy as monotherapy was indicated. A
total of 88 stranded brachytherapy seeds were implanted
anteriorly to posteriorly using transrectal ultrasound and
fluoroscopy (Fig. 1). At the end of the procedure, x-ray and
ultrasound were used to assess for aberrant seeds, and a
cystoscopy revealed no misplaced seeds within the bladder.lared that no competing
Calvert).
Elsevier Inc. under copy
se (http://creativecommoOne month after the procedure, a computed tomography
(CT) of the pelvis without contrast showed multiple implant
seeds within the prostate gland (Fig. 2). Postoperative dosim-
etry was also performed and demonstrated dose volume
values that were lower than expected. Theminimum planned
dose was 145 Gy, yet the patient had a dose volume of 137.67
Gy, or 94.94% of planned dose, and a V100 of 87.38%. The dose
reductionwas attributed to breaks in the dose distributions, or
isodose lines, at the base of the prostate.
Approximately 6 years later, the patient presented to his
primary care provider complaining of dyspnea and due to his
history of prostate cancer, a chest radiograph was ordered to
assess for metastasis. The chest radiograph revealed multiple
linear metallic densities overlying the right suprahilar lung
suggestive of involvement in the ascending branches of theinterests exist.
right license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
Fig. 1 e A 56-year-old male with brachytherapy seeds in
prostate. Technique: Fluoroscopy. Findings: Operative
fluoroscopy was used for assistance in brachytherapy
implantation seeds within the prostate. Approximate
fluoroscopy time was greater than 1-hour standard.
R a d i o l o g y C a s e R e p o r t s x x x ( 2 0 1 6 ) 1e52right upper pulmonary artery. Additional findings included
scarring of both lung bases and slight hyperexpansion (Fig. 3).
A thoracic CT without contrast confirmed that the densities
were located within the pulmonary artery branches of the
right upper lobe and also demonstrated moderate cen-
trilobular emphysematous changes predominantly in the
upper lobes (Fig. 4). The patient exhibited a significantly
higher seed migration rate (8%) than those demonstrated in
published studies (~0.08%). Management of care was directed
by the primary care provider and did not include a further
workup within our health care system.Discussion
Etiology
Prostate brachytherapy requires placement of radioactive
sources or seeds within target tissue and provides aFig. 2 e A 56-year-old male with brachytherapy seeds in prosta
without contrast. A 2.5-mm contiguous imaging was obtained. F
consistent with radiation implant seeds. Superior (A) and inferihigh-radiation dose to the tumor with only a modest dose to
surrounding normal tissue. The standard technique uses
either a transrectal or transperineal ultrasound-guided
approach to visualize placement of the radioactive seeds.
Permanent implants are commonly used to provide LDR
radiation with a high total dose, which is indicated in low-risk
and select low-volume intermediate-risk prostate cancers [1].
Steinfeld et al. were the first to report pulmonary seed
embolization as a complication after prostatic brachytherapy
[2]. Ensuing studies varied in tumor and patient characteris-
tics but have determined that key parameters influencing the
incidence and rate of seed embolization included planning
volume, the number of seeds, seed placement, and type of
seeds (stranded vs free) [3e5]. The planning volume
determines the number of seeds required for implantation,
thus an increased planning volume requires a greater quantity
of seeds. Merrick et al. found that planning volume and seed
quantity of the brachytherapy plan correlated with local seed
loss and raised the overall probability of seed migration [5].
Seed placement is a major factor in developing a brachy-
therapy plan, and current techniques are generally based on
peripheral loading to reduce the dose to the urethra [4].
Unfortunately, prostatic tissue is an unpredictable matrix,
and seeds implanted close to the prostatic margin can shift
into the dense venous plexus surrounding the prostate
resulting in distal site migration [2]. Additionally, seed place-
ment never completely mirrors the ideal plan, and amargin of
error is expected [6]. Another risk factor for embolization is
the type of seeds used for the brachytherapy. Because
stranded seeds were introduced over a decade ago, free seeds
are used less frequently in prostatic brachytherapy [7].
Stranded seeds have a tissue absorbable suture linking the
seeds together and absorption occurs between 60 and 90 days
postoperatively, which is adequate time for epithelialization
to occur [4]. Multiple studies have demonstrated the effect of
stranded seeds to substantially lower the incidence of seed
migration, particularly to the lung. At dose delivery, 5.5% of
cases with free seeds had seed migration, whereas those with
stranded seeds had no migration initially. After 4 months,
25.3% of cases with free seeds demonstrated a migration
versus only 3.8% of those with stranded seeds. Although seed
embolization had a considerable incidence, only 24 of 31,856
stranded seedsmigrated to the pulmonary vasculature. Owingte. Technique: Axial computed tomography (CT) of pelvis
indings: Multiple small densities within the prostate gland
or view (B) provided.
Fig. 3 e A 56-year-old male with brachytherapy seed migration. Technique: Frontal (posterior to anterior technique) and
lateral chest radiograph. Findings: Frontal chest radiograph demonstrates six migrated brachytherapy seeds in right
suprahilar lung (A), which is better illustrated in a magnified view (B). Lateral chest radiograph demonstrates seven
brachytherapy seeds located in right suprahilar lung suggestive of involvement in the ascending branches of the right upper
pulmonary artery (C). Two seeds are adjacent to each other and best appreciated in a magnified view (yellow arrow in D).
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films, the total number of migrated seeds is likely higher than
reported because most of the seeds were from a study that
evaluated migration before suture resorption and reported no
seed migration. In the two studies that evaluated for migra-
tion after 90 days, stranded seed migration to the pulmonary
vasculature was more common (16.8% of cases, 0.2% of
implanted seeds) and is likely a better indicator of true seed
migration [8].
Imaging findings
Brachytherapy seeds are tiny, linear seeds with a silver or
titanium shell that create a distinct radiopaque pattern
easily identified on chest radiographs. Despite the unique
pattern, visualization may be influenced by several factors to
include obstructed visibility in high-attenuation regions [9].
Computed tomography (CT) of the chest depicts brachyther-
apy seeds as punctate hyperdense attenuations with streak
artifacts which can obscure the image and limit soft-tissue
contrast near the seeds [10]. CT is useful in the detection of
radiation-induced lung disease and exact localization of the
seeds; however, the chest radiograph provides greater
appreciation of seed appearance [11,12].
Treatment and prognosis
One concern of brachytherapy seed embolization is the dose
reduction to the prostate gland. Studies have shown that <1%
of all implanted brachytherapy seeds migrate (0.34% for free
seeds and 0.08% of stranded seeds) which indicates that even
in embolization cases, the vast majority of seeds remain
within the prostate and have little to no impact on the dose [8].
Additionally, Lee et al. demonstrated that stranded seeds hadincreased activity per unit volume and significantly improved
dosimetry quantifiers when compared to free seeds (mean
V100 for stranded was 94.10% compared to 86.54%) [13].
Although both groups achieved adequate dosing, the dosim-
etry differences were due to local seed loss and the greater
propensity for free seeds to migrate. In our case, the patient
had a significant migration rate of 8% of implanted seeds, yet
the radiation dose remained adequate for treatment with a
V100 of 87.38%.
An additional concern of seed embolization includes
iatrogenic irradiation, particularly within the first fewmonths
after the procedure. Although retrospective studies are
lacking, the average energy of 28 keV for 125-I could poten-
tially cause irradiation damage to nonrenewing tissues and
predispose to adverse sequelae to include pneumonitis and
carcinogenesis [4]. Several studies have demonstrated that
multiple seed emboli can damage normal lung tissue in
limited volumes because dose distribution varies based on
lung tissue density [14,15]. In fact, several reports have
described serious adverse outcomes to include radiation
pneumonitis, small-cell lung cancer, and an acute myocardial
infarction without evidence of a shunt [16e18]. Although the
incidence rates varied between studies due to seed placement
techniques and timing of postimplant imaging studies, none
showed any identifiable short-term sequelae. Ankem et al.
suggested that if postimplant chest x-rays reveal seed
migration, patients should be informed and followed on a
long-term basis with chest radiographs and pulmonary
function studies [14]. In our particular case, the patient
presented years after brachytherapy with dyspnea and an
incidental finding of multiple brachytherapy seeds within the
pulmonary vasculature. The embolized seeds could not be
directly attributed as the cause of the patient's symptoms but
there was minimal impact if that were the case. Additionally,
Fig. 4 e A 56-year-old male with brachytherapy seed migration. Technique: Axial and coronal CT images of the thorax
without contrast. Findings: Seven brachytherapy seeds (two of which are adjacent to one another in (B)) located within the
pulmonary artery branches of the right upper lobe (red arrowheads). Moderate centrilobular emphysematous changes
predominately in the upper lobes. Images oriented from superior (A) to inferior (D). Two brachytherapy seeds adjacent to
one another within the pulmonary artery branches of the right upper lobe (E).
R a d i o l o g y C a s e R e p o r t s x x x ( 2 0 1 6 ) 1e54a postimplant chest x-ray or CT would not have changed the
course of management for our patient and would therefore be
unwarranted.Differential diagnosis
The differential diagnosis of brachytherapy seed migration to
the pulmonary arteries includes foreign objects, segmental
atelectasis, and emboli from iodized oil, acrylic cement, or
metallic mercury. Foreign objects consisting of metallic
materials or glass are radiopaque and easily detected on
radiograph [12]. Segmental atelectasis may present as broad,
linear opacities that could give the appearance of brachy-
therapy seeds but typically conforms to the anatomic distri-
bution of bronchopulmonary segments rather than the course
of pulmonary vessels [19].Iodized oil, or lipiodol, is used in the management of
iodine deficiency and locally unresectable hepatocellular
carcinoma to promote chemotherapy retention. Embolization
is a complication of the treatment and can appear in the
upper lobes as multiple radiopaque densities without
evidence of pulmonary parenchymal abnormality. When
compared to the surrounding vasculature, the hyperdense
segments of the pulmonary vasculature will have a plaster-
cast-like appearance [20].
Pulmonary cement embolism can occur after
percutaneous vertebroplasty as a result of leakage of
polymethylmethacrylate, an acrylic cement, into the peri-
vertebral venous system, and subsequently, the inferior vena
cava. The emboli appear as multiple high-density opacities
in a tubular branching pattern scattered sporadically or
distributed diffusely throughout the lungs corresponding to
pulmonary arterial distribution [21,22].
R a d i o l o g y C a s e R e p o r t s x x x ( 2 0 1 6 ) 1e5 5Embolization of metallic mercury is very rare and usually
causedbydeliberate injectionofmercury intoaperipheral vein
from a suicide attempt or drug abuse. Metallicmercury emboli
are usually asymptomatic and appear as small globules in the
peripheral branches of the pulmonary arteries, sometimes as
beaded chains filling pulmonary arterioles [23,24].Teaching point
After a prostatic brachytherapy procedure, seed embolization
to the pulmonary vasculature is a potential complication
with the greatest risk within 90 days of placement. Because
brachytherapy has assumed an increasing role in the
management of early-stage prostate cancer, providers should
be aware of the complication and understand that the clinical
implications are minimal at worst based on current studies
and our particular case; therefore, screening and monitoring
are unnecessary.Acknowledgment
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